Pleura and Peritoneum

Scope & Guideline

Connecting researchers and practitioners for better outcomes.

Introduction

Welcome to your portal for understanding Pleura and Peritoneum, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2364-7671
PublisherWALTER DE GRUYTER GMBH
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationPLEURA PERITONEUM / Pleura Peritoneum
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGENTHINER STRASSE 13, D-10785 BERLIN, GERMANY

Aims and Scopes

The journal 'Pleura and Peritoneum' focuses on advancing the understanding and treatment of diseases affecting the pleura and peritoneum, with a particular emphasis on innovative surgical techniques and therapeutic approaches. The journal aims to facilitate the dissemination of research findings that contribute to improved outcomes for patients with pleural and peritoneal malignancies.
  1. Focus on Peritoneal and Pleural Malignancies:
    The journal primarily addresses the complexities associated with peritoneal and pleural cancers, including treatment methodologies, surgical interventions, and innovative therapeutic strategies.
  2. Innovations in Chemotherapy Techniques:
    A significant emphasis is placed on emerging chemotherapy techniques such as Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and Pressurized IntraThoracic Aerosol Chemotherapy (PITAC), showcasing their applications and outcomes in treating metastatic diseases.
  3. Surgical Techniques and Outcomes:
    Research published often explores various surgical techniques, including cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), focusing on their effectiveness and safety in managing peritoneal surface malignancies.
  4. Clinical and Diagnostic Research:
    The journal includes studies that investigate the diagnostic and prognostic factors related to pleural and peritoneal diseases, aiming to enhance clinical decision-making and patient management.
  5. Patient-Centric Approaches:
    There is a consistent focus on the quality of life, patient outcomes, and the implementation of enhanced recovery protocols in surgical oncology, reflecting a commitment to holistic patient care.
Recent publications indicate a dynamic shift in the journal's focus towards innovative treatment modalities and a deeper understanding of pleural and peritoneal diseases. Emerging themes highlight the journal's responsiveness to current clinical challenges and advancements.
  1. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC):
    PIPAC has become a prominent topic within the journal, reflecting its emerging role as a promising treatment for peritoneal metastasis, with numerous studies assessing its efficacy and safety.
  2. Enhanced Recovery After Surgery (ERAS) Protocols:
    There is an increasing focus on implementing ERAS protocols in surgical oncology, emphasizing the importance of improving recovery times and patient outcomes post-surgery.
  3. Meta-Analysis and Systematic Reviews:
    The journal is seeing a rise in meta-analyses and systematic reviews that synthesize existing data on surgical and chemotherapy techniques, providing comprehensive insights into treatment efficacy and safety.
  4. Patient Quality of Life and Prognostic Factors:
    Emerging themes include the assessment of quality of life and the identification of prognostic biomarkers, which are becoming crucial for tailoring treatment approaches and improving patient care.
  5. Multicenter Trials and Collaborative Research:
    An increase in multicenter trials and collaborative studies is evident, indicating a trend towards more extensive data collection and analysis to enhance the robustness of research findings.

Declining or Waning

While the journal continues to thrive in various areas, certain themes appear to be declining in prominence over recent years. This may reflect shifts in research focus or advancements in understanding and treatment methodologies.
  1. Traditional Chemotherapy Approaches:
    Research related to traditional chemotherapy methods appears to be waning, as newer approaches like PIPAC gain traction, highlighting a shift towards more innovative and targeted therapies.
  2. Basic Science Studies:
    There seems to be a decrease in purely basic science studies that do not directly correlate with clinical applications. As the journal's focus sharpens on clinical and translational research, foundational studies may be less represented.
  3. General Surgical Techniques:
    Papers focusing on general surgical techniques without a specific connection to pleural or peritoneal conditions are becoming less common, as the journal prioritizes specialized surgical approaches that directly impact patient outcomes.

Similar Journals

Journal of Bone Oncology

Bridging Science and Practice in Bone Cancer Care
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Journal of Bone Oncology, published by ELSEVIER, is a pivotal open access journal that has been advancing the field of oncology since its inception in 2012. Focused on the intricate relationship between bone-related malignancies and therapeutic advancements, this journal addresses critical issues in bone oncology, including novel treatments, diagnostic methodologies, and translational research. With a commendable impact factor reflecting its scholarly contributions and ranking in the Q2 category of oncology journals (2023), the Journal of Bone Oncology is recognized within the top 67th percentile across Scopus rankings, showcasing its relevance and quality in the medical oncology landscape. Available in open access, the journal promotes widespread dissemination of knowledge, ensuring that researchers, professionals, and students can access groundbreaking research that informs clinical practices and enhances patient outcomes. Located in Germany and targeting a global audience, the journal’s wealth of resources serves as an essential platform for fostering collaboration and innovation in the oncology community.

JAMA Otolaryngology-Head & Neck Surgery

Fostering Excellence in Otolaryngology and Surgical Techniques
Publisher: AMER MEDICAL ASSOCISSN: 2168-6181Frequency: 12 issues/year

JAMA Otolaryngology-Head & Neck Surgery, published by the American Medical Association, stands as a preeminent journal in the fields of otolaryngology and head and neck surgery, recognized for its rigorous peer-reviewed research and valuable contributions to clinical practice. With an impressive impact factor and distinguished rankings, including Q1 in Medicine (miscellaneous), Otorhinolaryngology, and Surgery, it asserts its position as a leading source of knowledge, ranking 3rd in Otorhinolaryngology and 13th in Surgery within the esteemed Scopus database. The journal, which operates under open access policies from 2013 to 2024, strives to disseminate innovative findings and foster advancements in medical practices, making it an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing patient care in the intricate domains of head, neck, and throat health.

South Asian Journal of Cancer

Fostering innovation in South Asian cancer research.
Publisher: GEORG THIEME VERLAG KGISSN: 2278-330XFrequency: 4 issues/year

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

BREAST

Advancing breast health through cutting-edge research.
Publisher: CHURCHILL LIVINGSTONEISSN: 0960-9776Frequency: 6 issues/year

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

General Thoracic and Cardiovascular Surgery

Transforming Insights into Impactful Surgical Solutions
Publisher: SPRINGER JAPAN KKISSN: 1863-6705Frequency: 12 issues/year

General Thoracic and Cardiovascular Surgery is a pivotal academic journal dedicated to the rapidly evolving fields of thoracic and cardiovascular surgery. Published by SPRINGER JAPAN KK, this journal serves as a vital resource for clinicians, researchers, and medical professionals seeking insights into current practices, innovative techniques, and groundbreaking research. With an ISSN of 1863-6705 and an E-ISSN of 1863-6713, it has established a prominent presence in the academic community, demonstrated by its impressive ranking in the Q3 category for Cardiology and Cardiovascular Medicine and Surgery in 2023. The journal’s standards ensure high-quality, peer-reviewed articles that facilitate knowledge exchange and drive advancements in the field. Although it operates without open access, it remains accessible through library subscriptions and institutional affiliations. Covering a broad span of research from 2007 to 2024, General Thoracic and Cardiovascular Surgery is committed to enlightening its audience with findings that have substantial implications for clinical practices and patient outcomes.

CURRENT TREATMENT OPTIONS IN ONCOLOGY

Transforming Research into Real-World Oncology Solutions
Publisher: SPRINGERISSN: 1527-2729Frequency: 12 issues/year

CURRENT TREATMENT OPTIONS IN ONCOLOGY, published by Springer, is a premier academic journal dedicated to disseminating cutting-edge research and advancements in the field of oncology and pharmacology. With a commendable impact factor and ranked in the Q1 category in both oncology and pharmacology for 2023, this journal positions itself as a leading resource for researchers, healthcare professionals, and students alike, offering insightful reviews and original articles that critically evaluate treatment methodologies and clinical practices. Covering a wide scope of topics from early detection to innovative therapies, it fosters the translation of research findings into clinical applications. With its convergence years spanning from 2000 to 2024, CURRENT TREATMENT OPTIONS IN ONCOLOGY continues to be at the forefront of oncological research, providing a platform for scholars to explore the latest therapeutic options and improve patient outcomes. Highly regarded in the academic community, this journal is essential for anyone looking to stay informed about the dynamic landscape of cancer treatment.

Techniques in Coloproctology

Pioneering research in gastroenterology and surgery.
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 1123-6337Frequency: 12 issues/year

Techniques in Coloproctology is an esteemed, peer-reviewed journal hosted by SPRINGER-VERLAG ITALIA SRL, dedicated to advancing the fields of gastroenterology and surgery with a specific focus on innovative techniques and clinical practices in coloproctology. Since its inception in 1998, the journal has been instrumental in fostering knowledge and research dissemination, exemplified by its current recognition in the 2023 quartiles as Q2 in Gastroenterology and Q1 in Surgery, reflecting its impact and relevance within the medical community. With a notable Scopus ranking of #73/551 in Medicine - Surgery and #53/167 in Medicine - Gastroenterology, it serves as a vital resource for practitioners, researchers, and students alike. Although it is not an open-access journal, the journal provides a unique platform for interdisciplinary collaboration and the sharing of cutting-edge findings, pivotal to the ongoing evolution of surgical techniques. As it continues to publish high-quality research through 2024 and beyond, the journal remains at the forefront of improving outcomes in coloproctological practices.

PROSTATE

Innovating treatment through rigorous peer-reviewed studies.
Publisher: WILEYISSN: 0270-4137Frequency: 16 issues/year

PROSTATE is a premier, peer-reviewed journal published by Wiley, focusing on the critical fields of urology and oncology. With an established history since 1980 and a projected convergence through 2024, this influential journal serves as a vital resource for researchers, clinicians, and students alike. It holds a prestigious position in the academic landscape, classified in the Q1 category for Urology and Q2 in Oncology as of 2023, demonstrating its significant contribution to these disciplines. With a Scopus rank of #23 in Urology and #169 in Oncology, PROSTATE is pivotal for advancing knowledge and fostering innovation in prostate research, treatment, and overall male health. The journal aims to publish high-quality original articles, reviews, and clinical studies that address the complexities of prostate-related conditions, ultimately seeking to improve patient outcomes and propagate best practices in the medical community.

Journal of Gastrointestinal Oncology

Uncovering breakthroughs in cancer management and care.
Publisher: AME PUBLISHING COMPANYISSN: 2078-6891Frequency: 6 issues/year

The Journal of Gastrointestinal Oncology, published by AME Publishing Company, is a leading open-access journal that focuses on the complex interplay between gastroenterology and oncology. Established in 2012 and converging into a reputable academic platform through 2024, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and management of gastrointestinal cancers. With an ISSN of 2078-6891 and an E-ISSN of 2219-679X, this journal presents articles that are rigorously peer-reviewed, ensuring high-quality content that meets the demands of the scientific community. Despite its current categorization in the Q3 quartile for both Gastroenterology and Oncology as of 2023, it consistently strives to improve its impact and relevance, reflected in its Scopus rankings and percentile metrics. Publishing noteworthy research, reviews, and case studies, the Journal of Gastrointestinal Oncology is instrumental in addressing significant challenges in the field, making it a must-read for those dedicated to advancing knowledge and practice in gastrointestinal oncology.

Annali Italiani di Chirurgia

Pioneering Insights in Surgical Medicine
Publisher: EDIZIONI LUIGI POZZIISSN: 0003-469XFrequency: 6 issues/year

Annali Italiani di Chirurgia is a prestigious surgical journal published by EDIZIONI LUIGI POZZI, dedicated to advancing the field of medicine and surgery through the dissemination of high-quality research and clinical insights. Since its inception in 1947, this journal has served as a vital platform for surgeons, researchers, and healthcare professionals in Italy and beyond, publishing comprehensive studies that cover a wide array of surgical disciplines. With an impact factor reflecting its notable standing in the scholarly community, the journal currently ranks in the Q3 category of surgery according to the 2023 category quartiles, and holds a Scopus rank of #371 out of 551, placing it in the 32nd percentile. While the journal does not offer open access, its rigorous peer-review process ensures that only the most relevant and innovative research reaches its readership. Based in Rome, Italy, Annali Italiani di Chirurgia continues to play an essential role in shaping the future of surgical practice and research, making it a critical resource for anyone involved in the surgical sciences.